Cecilia Dupecher, Ph.D., Program Manager, Peer Reviewed Medical Research Program (PRMRP) at the U.S. Army’s Congressionally Directed Medical Research Programs (CDMRP) led an informative webinar briefly explaining the program’s history and purpose followed by a discussion on how researchers can apply for $370 million in awards under PRMRP as part of the fiscal year 2024 review cycle.

Myotonic Dystrophy researchers were awarded over $5 million as part of the fiscal year 2023 grant cycle. Since myotonic dystrophy was designated as an eligible research area, over $21 million has been allocated to advancing research in this critical field.

PRMRP Letters of Intent are due as early as March 6th with Full Application deadlines beginning April 23rd, 2024! Don’t miss this opportunity to learn the requirements for submitting your grant application so we can continue to grow federal support for myotonic dystrophy research! For General Application Instructions and more details on each Award Mechanism, visit the PRMRP hub on the Electronic Biomedical Research Application Portal (eBRAP).

About the Speaker

Cecilia Dupecher, Ph.D. 
Program Manager, Congressionally Directed Medical Research Programs 
U.S. Army Medical Research and Development Command

Dr. Dupecher provides strategic coordination for the execution and management of PRMRP Congressional appropriation. As the Program Manager, she is responsible for executing the PRMRP’s entire program life cycle, including investment strategy, development of funding opportunities, overseeing review of research proposals, and analysis of PRMRP’s accomplishments. She joined CDMRP in 2017 as Science Officer, providing scientific management and oversight to a portfolio of research awards focused on various Infectious Diseases, funded under the PRMRP.

Click here to read Dr. Dupecher's full bio!

Click here to the view the FY2024 PRMRP Awards (Summary Sheet).

Click here to visit the Electronic Biomedical Research Application Portal (eBRAP).